The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Multiplex Genome Engineering Using CRISPR/Cas Systems
Open accessAbstract
Genome Editing: Clustered regularly interspaced short palindromic repeats (CRISPR) function as part of an adaptive immune system in a range of prokaryotes: Invading phage and plasmid DNA is targeted for cleavage by complementary CRISPR RNAs (crRNAs) bound to a CRISPR-associated endonuclease (see the Perspective by van der Oost ). Cong et al. (p. 819 , published online 3 January) and Mali et al. (p. 823 , published online 3 January) adapted this defense system to function as a genome editing tool in eukaryotic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR/Cas9 is a class of ribonucleoprotein complexes formed by a Cas9 protein and a single guide RNA (sgRNA) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Cong et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cas9 is guided by a 20 nt fraction of the gRNA”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and it maintains cleaving activity even with 3-5 mismatches at the PAM-distal end of the gRNA molecule [59,81,102].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In January 2013, almost simultaneously, five research articles authored by different research teams appeared, all reporting that they had achieved the goal.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Target specificity of the CRISPR/Cas system is very high and a single mutation can disrupt targeting 20”
From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus (2013) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 can create DNA cleavage at desired genomic positions that are guided by precise base pairing between sgRNA and DNA, adjacent to a protospacer-adjacent motif (PAM) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Cong et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“By introducing an aspartate-to-alanine (D10A) mutation in the RuvC active domain of Cas9, the resulting mutant, Cas9 nickase, (Cas9n) will nick the target DNA, originating single-stranded breaks rather than DSB [54,81].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9n nicks the target DNA, originating single-stranded breaks rather than DSB [54,81].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“by introducing a specific mutation in the RuvC domain of Cas9, a Cas9 nickase variant (Cas9n) is created.”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“The markedly high efficiency of CRISPR/Cas systems coupled with the above-mentioned advantages over other methods justify the CRISPR “epidemic” that the scientific community experienced in 2013 [62,81,100,101].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“The pigs were engineered to carry 69 genomic edits, using the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9)-mediated nonhomologous end joining and homology-directed repair30,31, and recombinase-mediated cassette exchange32 (Fig. 2a, Extended Data Fig. 1a and Supplementary Table 2).”
From Design and testing of a humanized porcine donor for xenotransplantation (2023) · cites this paper as [30]
In the citing paper
“When a double-stranded break is introduced into genomic DNA, cells can repair the break by using a DNA molecule with high sequence similarity as a template. If an artificial template is provided while the DNA break is introduced, this pathway provides a mean to incorporate desired DNA sequences into the genome34,35”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [34]
In the citing paper
“The discovery, made less than 10 years ago, that a simple two-component system of a Cas protein (Streptococcus pyogenes Cas9) bound to a single guide RNA (sgRNA) can function as a programmable nuclease33 that can be deployed to cleave specific sequences in mammalian genomes34,35 has been transformative for biomedical research and the development of gene therapies.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [34]
In the citing paper
“The CRISPR/Cas9 system has been used for multiplex genome cleavage.20”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [20]
In the citing paper
“Recently, the CRISPR/Cas system has been successfully applied to human cells19,20,21,22 and several model organisms for genome editing.23,24,25,26”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [20]
In the citing paper
“selection of LTR-A-and -B-directed, 30-bp protospacer and also precrRNA system reflecting the original bacterial immune mechanism to enhance specificity/efficiency vs. 20-bp protospacer-based, chimeric crRNA-tracRNA system”
From RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection (2014) · cites this paper as [16]
In the citing paper
“as mentioned in several recent publications, Cas9 tolerates mismatches between the guide RNA and target DNA in a sequence-dependent manner and potentially tolerates up to five target mismatches in human cells [12], [24], [25], [26], [27], thereby promoting undesired off-target mutations.”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [12]
In the citing paper
“Because the sequence specificity of Streptococcus pyogenes Cas9 tolerates 4 mismatches between the gRNA and complementary sequence”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [12]
In the citing paper
“Compared with well-known, site-specific genome editing technologies, such as ZFNs and TALENs, the new CRISPR-Cas approach is more convenient and efficient [10], [12].”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [12]
In the citing paper
“non-specific cleavage may occur in the cellular genome [12], [24], [25], [26], [27].”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [12]
In the citing paper
“Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 is a naturally occurring bacterial immune system that uses a novel nuclease system to protect bacteria from phage infection (6-9), and it has recently been harnessed for a variety of genome-engineering applications (10)(11)(12)(13)(14)(15)(16)(17).”
From RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection (2014) · cites this paper as [11]
In the citing paper
“In the few available publications using CRISPR/Cas9 system, the gene editing frequency is comparable with ZFN or TALEN [87].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“Collectively, these studies indicate that although each base within the 20 nt guide sequence contributes to overall specificity”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“As described by Zhang group [87], CRISPR/Cas 9 system can be easily employed to target multiple sites to induce a deletion of a large gene fragment.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“multiple mismatches between the guide RNA and its complementary target DNA sequence can be tolerated depending on the quantity, position, and base identity of mismatches [87,90,91,93], all of which contribute to potential off-target activity.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“Moreover, no significant cytotoxicity was observed [87,88].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [87]
In the citing paper
“while in December 2012 Zhang and the Broad Institute also submitted a patent application [43] simultaneously with the acceptance of Zhang’s paper on human cells’ editing for publication in Science [35].”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
Mechanisms of gene silencing by double-stranded RNA
Meister, G., & Tuschl, T. (2004) · Nature · doi:10.1038/nature02873 · Cited by 2,598
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., Lahaye, T., Nickstadt, A., & Bonas, U. (2009) · Science · doi:10.1126/science.1178811 · Cited by 2,470
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,336
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,214
CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity
Lazzarotto, C. R., Malinin, N. L., Li, Y., Zhang, R., Yang, Y., Lee, G., Cowley, E., He, Y., Lan, X., Jividen, K., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0555-7 · Cited by 294
CRISPR/Cas9‐mediated mutagenesis of lncRNA1459 alters tomato fruit ripening
Li, R., Fu, D., Zhu, B., Luo, Y., & Zhu, H. (2018) · The Plant Journal · doi:10.1111/tpj.13872 · Cited by 281
Genetic identification of leptin neural circuits in energy and glucose homeostases
Xu, J., Bartolome, C. L., Low, C., Yi, X., Chien, C.-H., Wang, P., & Kong, D. (2018) · Nature · doi:10.1038/s41586-018-0049-7 · Cited by 289
Complete chemical structures of human mitochondrial tRNAs
Suzuki, T., Yashiro, Y., Kikuchi, I., Ishigami, Y., Saito, H., Matsuzawa, I., Okada, S., Mito, M., Iwasaki, S., Ma, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18068-6 · Cited by 281
Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleasesPreprint
Sung, Y. H., Kim, J. M., Kim, H.-T., Lee, J., Jeon, J., Jin, Y., Choi, J.-H., Ban, Y. H., Ha, S., Kim, C., et al. (2013) · Genome Research · doi:10.1101/gr.163394.113 · Cited by 287
Friedland, A. E., Baral, R., Singhal, P., Loveluck, K., Shen, S., Sanchez, M. E., Marco, E., Gotta, G. M., Maeder, M. L., Kennedy, E. M., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0817-8 · Cited by 285
An alternative strategy for targeted gene replacement in plants using a dual-sgRNA/Cas9 design
Zhao, Y., Zhang, C., Liú, W., Gao, W., Liu, C., Song, G., Li, W., Mao, L., Chen, B., Xu, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23890 · Cited by 285
Plant genome editing with TALEN and CRISPR
Malzahn, A. A., Lowder, L. G., & Qi, Y. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0148-4 · Cited by 288
SLERT Regulates DDX21 Rings Associated with Pol I Transcription
Xing, Y., Yao, R.-W., Zhang, Y., Guo, C., Jiang, S., Xu, G., Dong, R., Yang, L. C., & Chen, L. (2017) · Cell · doi:10.1016/j.cell.2017.04.011 · Cited by 280
Next-generation stem cells — ushering in a new era of cell-based therapies
Kimbrel, E. A., & Lanza, R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0064-x · Cited by 295
Capturing human trophoblast development with naive pluripotent stem cells in vitro
Io, S., Kabata, M., Iemura, Y., Semi, K., Morone, N., Minagawa, A., Wang, B., Okamoto, I., Nakamura, T., Kojima, Y., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.03.013 · Cited by 281
Genome modification by CRISPR /Cas9
Ma, Y., Zhang, L., & Huang, X. (2014) · FEBS Journal · doi:10.1111/febs.13110 · Cited by 304
Efficient nonmeiotic allele introgression in livestock using custom endonucleases
Tan, W. S., Carlson, D. F., Lancto, C. A., Garbe, J., Webster, D. A., Hackett, P. B., & Fahrenkrug, S. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310478110 · Cited by 283
CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing
Moreno-Mateos, M. A., Fernández, J. P., Rouet, R., Vejnar, C. E., Lane, M., Mis, E. K., Khokha, M. K., Doudna, J. A., & Giráldez, A. J. (2017) · Nature Communications · doi:10.1038/s41467-017-01836-2 · Cited by 288
Rapid breeding of parthenocarpic tomato plants using CRISPR/Cas9
Ueta, R., Abe, C., Watanabe, T., Sugano, S. S., Ishihara, R., Ezura, H., Osakabe, Y., & Osakabe, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-00501-4 · Cited by 256
Guler, G. D., Tindell, C. A., Pitti, R., Wilson, C., Nichols, K., KaiWai Cheung, T., Kim, H.-J., Wongchenko, M., Yan, Y., Haley, B., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.002 · Cited by 277
Synthetic biology in mammalian cells: next generation research tools and therapeutics
Lienert, F., Lohmueller, J. J., Garg, A. D., & Silver, P. A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3738 · Cited by 283
Greiner, A., Kelterborn, S., Evers, H., Kreimer, G., Sizova, I. A., & Hegemann, P. (2017) · The Plant Cell · doi:10.1105/tpc.17.00659 · Cited by 284
Mosaicism in CRISPR/Cas9-mediated genome editing
Mehravar, M., Shirazi, A., Nazari, M., & Banan, M. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.10.008 · Cited by 287
Pinder, J. B., Salsman, J., & Dellaire, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv993 · Cited by 290
Machine Learning in Genomic Medicine: A Review of Computational Problems and Data Sets
Leung, M. K. K., Delong, A., Alipanahi, B., & Frey, B. J. (2015) · Proceedings of the IEEE · doi:10.1109/jproc.2015.2494198 · Cited by 284
OsMATL mutation induces haploid seed formation in indica rice
Yao, L., Zhang, Y. P., Liu, C., Liu, Y., Wang, Y., Liang, D., Liu, J., Sahoo, G., & Kelliher, T. (2018) · Nature Plants · doi:10.1038/s41477-018-0193-y · Cited by 282
Dugar, G., Herbig, A., Förstner, K. U., Heidrich, N., Reinhardt, R., Nieselt, K., & Sharma, C. M. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003495 · Cited by 286
CRISPR/Cas9-Mediated Immunity to Geminiviruses: Differential Interference and Evasion
Ali, Z., Ali, S., Tashkandi, M., Zaidi, S. S., & Mahfouz, M. M. (2016) · Scientific Reports · doi:10.1038/srep26912 · Cited by 282
Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks
Brinkman, E. K., Chen, T., de Haas, M., Holland, H. A., Akhtar, W., & van Steensel, B. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.04.016 · Cited by 287
Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2
Ungewickell, A., Bhaduri, A., Rios, E. J., Reuter, J., Lee, C. S., Mah, A., Zehnder, A. M., Ohgami, R. S., Kulkarni, S., Armstrong, R. J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3370 · Cited by 281
CRISPR-Cas9 for cancer therapy: Opportunities and challenges
Chen, M., Mao, A., Xu, M., Weng, Q., Mao, J., & Ji, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.017 · Cited by 272
Integrated stress response of vertebrates is regulated by four eIF2α kinases
Taniuchi, S., Miyake, M., Tsugawa, K., Oyadomari, M., & Oyadomari, S. (2016) · Scientific Reports · doi:10.1038/srep32886 · Cited by 272
Emerging and evolving concepts in gene essentiality
Rancati, G. I., Moffat, J., Typas, A., & Pavelka, N. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.74 · Cited by 279
CRISPR/cas systems redefine nucleic acid detection: Principles and methods
Wang, M., Zhang, R., & Li, J. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112430 · Cited by 273
Near-infrared upconversion–activated CRISPR-Cas9 system: A remote-controlled gene editing platform
Pan, Y., Yang, J., Luan, X., Liu, X., Li, X., Yang, J., Huang, T., Sun, L., Wang, Y., Lin, Y., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav7199 · Cited by 272
Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering
Wada, N., Ueta, R., Osakabe, Y., & Osakabe, K. (2020) · BMC Plant Biology · doi:10.1186/s12870-020-02385-5 · Cited by 279
DNA synthesis technologies to close the gene writing gap
Hoose, A., Vellacott, R., Storch, M., Freemont, P. S., & Ryadnov, M. G. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00456-9 · Cited by 295
CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10
Ruan, G.-X., Barry, E., Yu, D., Lukason, M., Cheng, S. H., & Scaria, A. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.12.006 · Cited by 270
CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots
Cai, Y., Chen, L., Liu, X., Sun, S., Wu, C., Jiang, B., Han, T., & Hou, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136064 · Cited by 270
Structural basis for mismatch surveillance by CRISPR–Cas9
Bravo, J. P. K., Liu, M., Hibshman, G. N., Dangerfield, T. L., Jung, K., McCool, R. S., Johnson, K. A., & Taylor, D. W. (2022) · Nature · doi:10.1038/s41586-022-04470-1 · Cited by 282
Repurposing CRISPR-Cas12b for mammalian genome engineering
Teng, F., Cui, T., Feng, G., Guo, L., Xu, K., Gao, Q., Li, T., Li, J., Zhou, Q., & Li, W. (2018) · Cell Discovery · doi:10.1038/s41421-018-0069-3 · Cited by 272
The CRISPR/Cas Genome-Editing Tool: Application in Improvement of Crops
Khatodia, S., Bhatotia, K., Passricha, N., Khurana, S. M. P., & Tuteja, N. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00506 · Cited by 267
Intrinsic Dynamics of a Human Gene Reveal the Basis of Expression Heterogeneity
Rodriguez, J., Ren, G., Day, C. R., Zhao, K., Chow, C. C., & Larson, D. R. (2018) · Cell · doi:10.1016/j.cell.2018.11.026 · Cited by 262
Cas9 versus Cas12a/Cpf1: Structure–function comparisons and implications for genome editing
Swarts, D. C., & Jinek, M. (2018) · WIREs RNA · doi:10.1002/wrna.1481 · Cited by 267
Efficient and Heritable Gene Targeting in Tilapia by CRISPR/Cas9
Li, M., Yang, H., Zhao, J., Fang, L., Shi, H., Li, M., Sun, Y.-L., Zhang, X., Jiang, D., Zhou, L., et al. (2014) · Genetics · doi:10.1534/genetics.114.163667 · Cited by 268
Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9
Du, H., Zeng, X., Zhao, M., Cui, X., Wang, Q., Yang, H., Cheng, H., & Yu, D. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.11.005 · Cited by 270
Consequences of Cas9 cleavage in the chromosome of Escherichia coli
Cui, L., & Bikard, D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw223 · Cited by 278
Programmed genome editing by a miniature CRISPR-Cas12f nuclease
Wu, Z., Zhang, Y., Yu, H., Pan, D. Y., Wang, Y., Wang, Y., Li, F., Liu, C., Nan, H., Chen, W., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00868-6 · Cited by 271
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell linePreprint
Essletzbichler, P., Konopka, T., Santoro, F., Chen, D., Gapp, B. V., Královics, R., Brummelkamp, T. R., Nijman, S. M. B., & Bürckstümmer, T. (2014) · Genome Research · doi:10.1101/gr.177220.114 · Cited by 277
A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing
Edraki, A., Mir, A., Ibraheim, R., Gainetdinov, I., Yoon, Y., Song, C.-Q., Cao, Y., Gallant, J., Xue, W., Rivera-Pérez, J. A., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.12.003 · Cited by 265
DEG 15, an update of the Database of Essential Genes that includes built-in analysis tools
Luo, H., Lin, Y., Liu, T., Lai, F.-L., Zhang, C., Gao, F., & Zhang, R. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa917 · Cited by 272
CRISPR technologies for genome, epigenome and transcriptome editing
Villiger, L., Joung, J., Koblan, L. W., Weissman, J. S., Abudayyeh, O. O., & Gootenberg, J. S. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00697-6 · Cited by 280
Synthetic nucleases for genome engineering in plants: prospects for a bright future
Puchta, H., & Fauser, F. (2013) · The Plant Journal · doi:10.1111/tpj.12338 · Cited by 275
Kang, X., He, W., Huang, Y., Qian, Y., Chen, Y., Gao, X., Sun, X., & Fan, Y. (2016) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-016-0710-8 · Cited by 271
BTG4 is a meiotic cell cycle–coupled maternal-zygotic-transition licensing factor in oocytes
Yu, C. Y., Ji, S., Sha, Q., Dang, Y., Zhou, J.-J., Zhang, Y., Liu, Y., Wang, Z., Hu, B., Sun, Q., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3204 · Cited by 263
Vaidyanathan, S., Azizian, K. T., Haque, A. K. M. A., Henderson, J. M., Hendel, A., Shore, S., Antony, J. S., Hogrefe, R. I., Kormann, M. S. D., Porteus, M. H., et al. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.010 · Cited by 262
CRISPR/Cas9‐mediated genome engineering: An adeno‐associated viral (AAV) vector toolbox
Senís, E., Fatouros, C., Große, S., Wiedtke, E., Niopek, D., Mueller, A., Börner, K., & Grimm, D. (2014) · Biotechnology Journal · doi:10.1002/biot.201400046 · Cited by 268
Weninger, A., Hatzl, A.-M., Schmid, C., Vogl, T. J., & Glieder, A. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.03.027 · Cited by 271
Gene Targeting by Homology-Directed Repair in Rice Using a Geminivirus-Based CRISPR/Cas9 System
Wang, M., Lu, Y., Botella, J. R., Mao, Y., Hua, K., & Zhu, J. (2017) · Molecular Plant · doi:10.1016/j.molp.2017.03.002 · Cited by 262
Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization
Roberts, B., Haupt, A., Tucker, A., Grancharova, T., Arakaki, J., Fuqua, M. A., Nelson, A., Hookway, C., Ludmann, S. A., Mueller, I. A., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-03-0209 · Cited by 262
CRISPR/Cas9-Mediated Targeted Mutagenesis in the Liverwort Marchantia polymorpha L.
Sugano, S. S., Shirakawa, M., Takagi, J., Matsuda, Y., Shimada, T., Hara‐Nishimura, I., & Kohchi, T. (2014) · Plant and Cell Physiology · doi:10.1093/pcp/pcu014 · Cited by 269
Phosphorylated ubiquitin chain is the genuine Parkin receptor
Okatsu, K., Koyano, F., Kimura, M., Kosako, H., Saeki, Y., Tanaka, K., & Matsuda, N. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201410050 · Cited by 272
IFT27 Links the BBSome to IFT for Maintenance of the Ciliary Signaling Compartment
Eguether, T., San Agustin, J. T., Keady, B. T., Jonassen, J. A., Liang, Y., Francis, R., Tobita, K., Johnson, C. A., Abdelhamed, Z. A., Lo, C. W., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.09.011 · Cited by 260
DNA Sequence-Specific Binding of CENP-B Enhances the Fidelity of Human Centromere Function
Fachinetti, D., Han, J. S., McMahon, M. A., Ly, P., Abdullah, A., Wong, A. J., & Cleveland, D. W. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.03.020 · Cited by 260
The roles of CRISPR–Cas systems in adaptive immunity and beyond
Barrangou, R. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.12.008 · Cited by 276
Hu, J., Meyers, R. M., Dong, J., Panchakshari, R. A., Alt, F. W., & Frock, R. L. (2016) · Nature Protocols · doi:10.1038/nprot.2016.043 · Cited by 274
Genetically modified foods: A critical review of their promise and problems
Zhang, C., Wohlhueter, R. M., & Zhang, H. (2016) · Food Science and Human Wellness · doi:10.1016/j.fshw.2016.04.002 · Cited by 276
Increased efficiency of targeted mutagenesis by CRISPR/Cas9 in plants using heat stress
LeBlanc, C., Zhang, F., Mendez, J., Lozano, Y., Chatpar, K., Irish, V. F., & Jacob, Y. (2017) · The Plant Journal · doi:10.1111/tpj.13782 · Cited by 260
Self-citationBashir, S. S., Hussain, A., Hussain, S. J., Wani, O. A., Sheikh, Z. N., Dar, N. A., Baloch, F. S., & Mansoor, S. (2021) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2021.2020161 · Cited by 267
Cas9 immunity creates challenges for CRISPR gene editing therapies
Crudele, J. M., & Chamberlain, J. S. (2018) · Nature Communications · doi:10.1038/s41467-018-05843-9 · Cited by 259
Multi‐input CRISPR/Cas genetic circuits that interface host regulatory networks
Nielsen, A. A. K., & Voigt, C. A. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145735 · Cited by 259
Elucidating the Role of Effectors in Plant-Fungal Interactions: Progress and Challenges
Selin, C., de Kievit, T. R., Belmonte, M. F., & Fernando, W. G. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00600 · Cited by 275
De Ravin, S. S., Li, L., Wu, X., Choi, U., Allen, C., Koontz, S., Lee, J., Theobald-Whiting, N., Chu, J., Garofalo, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah3480 · Cited by 258
Self-citationZhu, X., Xu, Y., Yu, S., Lu, L., Ding, M., Cheng, J., Song, G., Gao, X., Yao, L., Fan, D., et al. (2014) · Scientific Reports · doi:10.1038/srep06420 · Cited by 264
TALEN-based Gene Correction for Epidermolysis Bullosa
Osborn, M. J., Starker, C. G., McElroy, A. N., Webber, B. R., Riddle, M. J., Xia, L., DeFeo, A. P., Gabriel, R., Schmidt, M., Von Kalle, C., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.56 · Cited by 258
Miyaoka, Y., Berman, J. R., Cooper, S., Mayerl, S. J., Chan, A. H., Zhang, B., Karlin-Neumann, G. A., & Conklin, B. R. (2016) · Scientific Reports · doi:10.1038/srep23549 · Cited by 277
Advances in therapeutic CRISPR/Cas9 genome editing
Savić, N., & Schwank, G. (2016) · Translational Research · doi:10.1016/j.trsl.2015.09.008 · Cited by 257
The mitochondrial calcium uniporter regulates breast cancer progression via HIF‐1α
Tosatto, A., Sommaggio, R., Kummerow, C., Bentham, R. B., Blacker, T. S., Berecz, T., Duchen, M. R., Rosato, A., Bogeski, I., Szabadkai, G., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606255 · Cited by 264
Piwowarek, K., Lipińska, E., Hać‐Szymańczuk, E., Kieliszek, M., & Ścibisz, I. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8616-7 · Cited by 258
Engineering resistance against Tomato yellow leaf curl virus via the CRISPR/Cas9 system in tomato
Tashkandi, M., Ali, Z., Aljedaani, F., Shami, A., & Mahfouz, M. M. (2018) · Plant Signaling & Behavior · doi:10.1080/15592324.2018.1525996 · Cited by 263
Zhuo, W., Liu, Y., Li, S., Guo, D., Sun, Q., Jin, J. F., Rao, X., Li, M., Sun, M., Jiang, M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.054 · Cited by 260
Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9
Singh, D., Sternberg, S. H., Fei, J., Doudna, J. A., & Ha, T. (2016) · Nature Communications · doi:10.1038/ncomms12778 · Cited by 269
BBSome trains remove activated GPCRs from cilia by enabling passage through the transition zone
Ye, F., Nager, A. R., & Nachury, M. V. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709041 · Cited by 256
“CRI SPR-based genome editing was conducted by transiently expressing Cas9 and guide RNA from plasmids derivative of pX330 (gift from F. Zhang, Massachusetts Institute of Technology, Cambridge, MA; 42230; Addgene; Cong et al., 2013).”
Steinert, J., Schiml, S., Fauser, F., & Puchta, H. (2015) · The Plant Journal · doi:10.1111/tpj.13078 · Cited by 261
Genome editing for crop improvement: Challenges and opportunities
Abdallah, N. A., Prakash, C. S., & McHughen, A. (2015) · GM crops & food · doi:10.1080/21645698.2015.1129937 · Cited by 267
Wang, W., Yao, L., Cheng, C.-Y., Zhang, T., Atsumi, H., Wang, L., Wang, G., Anilionyte, O., Steiner, H., Ou, J., et al. (2017) · Science Advances · doi:10.1126/sciadv.1601984 · Cited by 256
Chemical signaling involved in plant–microbe interactions
Chagas, F. O., Pessotti, R. D. C., Caraballo‐Rodríguez, A. M., & Pupo, M. T. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00343a · Cited by 259
Yuan, C., Tian, T., Sun, J. G., Hu, M., Wang, X., Xiong, E., Cheng, M., Bao, Y., Lin, W. H., Jiang, J., et al. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05597 · Cited by 258
“Perfect” designer chromosome V and behavior of a ring derivative.
Xie, Z.-X., Li, B.-Z., Mitchell, L. A., Wu, Y., Qi, X., Jin, Z., Jia, B., Wang, X., Zeng, B.-X., Liu, H.-M., et al. (2017) · Science · doi:10.1126/science.aaf4704 · Cited by 255
Self-citationCompetition between target sites of regulators shapes post-transcriptional gene regulation
Jens, M., & Rajewsky, N. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3853 · Cited by 267
Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies
Casanova, J., Conley, M. E., Seligman, S. J., Abel, L., & Notarangelo, L. D. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140520 · Cited by 255
Activation of the ATR kinase by the RPA-binding protein ETAA1
Haahr, P., Hoffmann, S., Tollenaere, M. A. X., Ho, T., Toledo, L. I., Mann, M., Bekker‐Jensen, S., Räschle, M., & Mailand, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3422 · Cited by 272
Ren, G., Jin, W., Cui, K., Rodrigez, J., Hu, G., Zhang, Z., Larson, D. R., & Zhao, K. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.08.026 · Cited by 265
Zhang, H., Qin, C., An, C., Zheng, X., Wen, S., Chen, W., Liu, X., Lv, Z., Yang, P., Xu, W., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01431-6 · Cited by 264
Streptococcus thermophilus CRISPR-cas9 systems enable specific editing of the human genome
Müller, M., Lee, C. M., Gasiunas, G., Davis, T. H., Cradick, T. J., Siksnys, V., Bao, G., Cathomen, T., & Mussolino, C. (2016) · Molecular Therapy · doi:10.1038/mt.2015.218 · Cited by 254
Autoimmune diseases — connecting risk alleles with molecular traits of the immune system
Gutiérrez‐Arcelus, M., Rich, S. S., & Raychaudhuri, S. (2015) · Nature Reviews Genetics · doi:10.1038/nrg.2015.33 · Cited by 256
Establishing RNA virus resistance in plants by harnessing CRISPR immune system
Zhang, T., Zheng, Q., Yi, X., An, H., Zhao, Y., Ma, S., & Zhou, G. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12881 · Cited by 260
Long, C., Li, H. Z., Tiburcy, M., Rodríguez-Caycedo, C., Kyrychenko, V., Zhou, H., Zhang, Y., Min, Y.-L., Shelton, J. M., Mammen, P. P. A., et al. (2018) · Science Advances · doi:10.1126/sciadv.aap9004 · Cited by 261
Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing
Robert, F., Barbeau, M., Ethier, S. D., Dostie, J., & Pelletier, J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0215-6 · Cited by 268
Emerging critical roles of Fe–S clusters in DNA replication and repair
Fuss, J. O., Tsai, C.-L., Ishida, J. P., & Tainer, J. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.018 · Cited by 262
Cancer-associated TERT promoter mutations abrogate telomerase silencing
Chiba, K., Johnson, J. Z., Vogan, J. M., Wagner, T., Boyle, J. M., & Hockemeyer, D. F. (2015) · eLife · doi:10.7554/elife.07918 · Cited by 257
Unlinking an lncRNA from Its Associated cis Element
Paralkar, V. R., Taborda, C., Huang, P., Yao, Y., Kossenkov, A. V., Prasad, R., Luan, J. Y., Davies, J. O. J., Hughes, J. R., Hardison, R. C., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.029 · Cited by 253
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs
Flavahan, W. A., Drier, Y., Johnstone, S. E., Hemming, M. L., Tarjan, D. R., Hegazi, E., Shareef, S. J., Javed, N. M., Raut, C. P., Eschle, B. K., et al. (2019) · Nature · doi:10.1038/s41586-019-1668-3 · Cited by 258
Precise genomic deletions using paired prime editing
Choi, J., Chen, W., Suiter, C. C., Lee, C., Chardon, F. M., Yang, W., Leith, A., Daza, R. M., Martin, B., & Shendure, J. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01025-z · Cited by 260
Metadata
- Authors
- Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., & Zhang, F.
- Affiliations
- Broad Institute (US)
- Columbia University (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- Rockefeller University (US)
- Corresponding author
- Cong, Le
- Ran, F. Ann
- Zhang, Feng
- ORCID
- Venue
- Science
- Published
- 2013-02-15
- Volume
- 339
- Issue
- 6121
- Pages
- 819-823
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3795411
- OpenAlex
- W2064815984
- Semantic Scholar
- 51bcf2a1577b3dd876fcaa4cdf630f54d261c107
- Cited by
- 15,339
- References
- 32
- Citations by year
- 2026: 614 · 2025: 926 · 2024: 1041 · 2023: 1127 · 2022: 1311 · 2021: 1421 · 2020: 1456 · 2019: 1399 · 2018: 1464 · 2017: 1368 · 2016: 1261 · 2015: 888 · 2014: 732 · 2013: 305
- FWCI
- 476.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Institute of Mental Health (DP1MH100706)
- National Cancer Institute (R01CA133404)
- National Institute of General Medical Sciences (R01GM034277, R01 GM34277, T32GM007753)
- National Institute of Allergy and Infectious Diseases (DP2AI104556)
- National Institute of Neurological Disorders and Stroke (R01NS073124)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided DNA cleavage, nicking enzyme, homology-directed repair, single guide RNA, CRISPR arrays, human cells, mouse cells, mutagenesis
- MeSH terms
- Animals, Base Sequence, DNA, Genetic Engineering, Humans, Molecular Sequence Data, RNA, Streptococcus pyogenes, Mutagenesis, Genome, Microarray Analysis, Mice, DNA Cleavage, Inverted Repeat Sequences, Genetic Loci, Recombinational DNA Repair, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
